Ashwin Gollerkeri
Corporate Officer/Principal presso KYMERA THERAPEUTICS, INC.
Profilo
Ashwin Gollerkeri is currently the Senior Vice President & Head-Development at Kymera Therapeutics, Inc. Previously, he held the same position at Array BioPharma, Inc. He completed his undergraduate degree at Northwestern University and his doctorate at Kansas City University of Medicine & Biosciences.
Posizioni attive di Ashwin Gollerkeri
| Società | Posizione | Inizio |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 03/02/2021 |
Precedenti posizioni note di Ashwin Gollerkeri
| Società | Posizione | Fine |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Formazione di Ashwin Gollerkeri
| Kansas City University of Medicine & Biosciences | Doctorate Degree |
| Northwestern University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KYMERA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Borsa valori
- Insiders
- Ashwin Gollerkeri
